Literatur
-
1
Thoelke A, Willrodt S, Hauschild A. et al .
Primary Extracutaneous Malignant Melanoma: A Comprehensive Review with Emphasis on Treatment.
Onkologie.
2004;
27
492-499
-
2
Chang A E, Karnell L H, Menck H R.
The national cancer date base report on cutaneous and noncutaneous melanoma.
Cancer.
1998;
83
1664-1678
-
3
Curtin J A, Busam K, Pinkel D. et al .
Somatic activation of KIT in distinct subtypes of Melanoma.
J Clin Oncol.
2006;
24
4340-4346
-
4
Malik A, Hull T L, Floruta C.
What is the best surgical treatment for anorectal melanoma?.
Int J Colorectal Dis.
2003;
27
27
-
5
Ross M, Pezzi C, Pezzi T. et al .
Patterns of failure in anorectal melanoma.
Arch Surg.
1990;
125
313
-
6 Arbeitsgemeinschaft Dermatologische Onkologie ADO .http://www.ado-homepage.de
-
7
Becker J C, Bröcker E B, Schadendorf D. et al .
Imatinib in Melanoma: A Selective Treatment Option Based on KIT Mutation Status?.
J Clin Oncol.
2007;
25
e9
Prof. Dr. med. Dirk Schadendorf
Klinik für Dermatologie, Venerologie und Allergologie
Universitätsklinikum Essen
Hufelandstraße 55
45122 Essen
eMail: Dirk.Schadendorf@uk-essen.de
